Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018, 392(10159):1736–1788.
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018, 392(10159):1923–1994.
Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16(4):223–37.
Forouzanfar MH, Alexander L, Anderson HR, Bachman VF, Biryukov S, Brauer M, Burnett R, Casey D, Coates MM, Cohen A, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(10010):2287–323.
Guo J, Zhu YC, Chen YP, Hu Y, Tang XW, Zhang B. The dynamics of hypertension prevalence, awareness, treatment, control and associated factors in Chinese adults: results from CHNS 1991–2011. J Hypertens. 2015;33(8):1688–96.
Wang X, Bots ML, Yang F, Hoes AW, Vaartjes I. Prevalence of hypertension in China: a systematic review and meta-regression analysis of trends and regional differences. J Hypertens. 2014;32(10):1919–27.
Xi B, Liang Y, Reilly KH, Wang Q, Hu Y, Tang W. Trends in prevalence, awareness, treatment, and control of hypertension among Chinese adults 1991–2009. Int J Cardiol. 2012;158(2):326–9.
Lu J, Lu Y, Wang X, Li X, Linderman GC, Wu C, Cheng X, Mu L, Zhang H, Liu J, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1.7 million adults in a population-based screening study (China PEACE Million Persons Project). Lancet. 2017;390(10112):2549–58.
Li YC, Yang L, Wang LM, Zhang M, Huang ZJ, Deng Q, Zhou MG, Chen ZM, Wang LH. Burden of hypertension in China: A nationally representative survey of 174,621 adults. Int J Cardiol. 2017;227:516–23.
Feng XL, Pang M, Beard J. Health system strengthening and hypertension awareness, treatment and control: data from the China Health and Retirement Longitudinal Study. Bull World Health Organ. 2014;92(1):29–41.
Wang J, Zhang L, Wang F, Liu L, Wang H. Prevalence, awareness, treatment, and control of hypertension in China: results from a national survey. Am J Hypertens. 2014;27(11):1355–61.
Howard AG, Attard SM, Herring AH, Wang H, Du S, Gordon-Larsen P. Socioeconomic gradients in the Westernization of diet in China over 20 years. SSM Popul Health. 2021;16: 100943.
Wang J, Wang Y, Korivi M, Chen X, Zhu R. Status of sedentary time and physical activity of rural residents: a cross-sectional population-based study in Eastern China. Front Public Health 2022;10.
Kun P, Liu Y, Pei X, Luo H. Regional and urban-rural disparities in prevalence of over-weight among old people in China: evidence from four Chinese provinces. J Nutr Health Aging. 2013;17(10):859–64.
Li J, Shi L, Li S, Xu L, Qin W, Wang H. Urban-rural disparities in hypertension prevalence, detection, and medication use among Chinese Adults from 1993 to 2011. Int J Equity Health. 2017;16(1):50.
Bundy JD, He J. Hypertension and related cardiovascular disease burden in China. Ann Glob Health. 2016;82(2):227–33.
Zhou D, Feng Z, He S, Sun X, Ma C, Lv B, Zou X. Equity of the essential public health service in rural china: evidence from a nationwide survey of hypertensive patients. Pak J Med Sci. 2013;29(4):1012–7.
Yip W, Fu H, Chen AT, Zhai T, Jian W, Xu R, Pan J, Hu M, Zhou Z, Chen Q, et al. 10 years of health-care reform in China: progress and gaps in Universal Health Coverage. Lancet. 2019;394(10204):1192–204.
Zhang D, Pan X, Li S, Liang D, Hou Z, Li Y, Shi L. Impact of the National Essential Public Health Services Policy on Hypertension Control in China. Am J Hypertens. 2017;31(1):115–23.
Zhao Y, Hu Y, Smith JP, Strauss J, Yang G. Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS). Int J Epidemiol. 2014;43(1):61–8.
Hou Z, Meng Q, Zhang Y. Hypertension prevalence, awareness, treatment, and control following China’s Healthcare Reform. Am J Hypertens. 2016;29(4):428–31.
Song Y. What should economists know about the current Chinese hukou system? China Econ Rev. 2014;29:200–12.
Ministry of Human Resources and Social Security of the People's Republic of China. 2018 Statistical Bulletin on the Development of Human Resources and Social Security. 2022. http://www.mohrss.gov.cn/SYrlzyhshbzb/zwgk/szrs/tjgb/201906/W020190611539807339450.pdf. Accessed 26th May 2022.
Zhou B. Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population. Zhonghua Liu Xing Bing Xue Za Zhi. 2002;23(1):5–10.
Song H, Feng D, Wang R, Yang J, Li Y, Gao J, Wang Z, Yan Z, Long C, Zhou J, et al. The urban-rural disparity in the prevalence and risk factors of hypertension among the elderly in China-a cross-sectional study. PeerJ. 2019;7:e8015.
Zhao Y, Atun R, Oldenburg B, McPake B, Tang S, Mercer SW, Cowling TE, Sum G, Qin VM, Lee JT. Physical multimorbidity, health service use, and catastrophic health expenditure by socioeconomic groups in China: an analysis of population-based panel data. Lancet Glob Health. 2020;8(6):e840–9.
Liu JA, Shi LZ, Meng QY, Khan MM: Income-related inequality in health insurance coverage: analysis of China Health and Nutrition Survey of 2006 and 2009. Int J Equity Health 2012;11.
Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, Bahonar A, Chifamba J, Dagenais G, Diaz R, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013;310(9):959–68.
Sani RN, Connelly PJ, Toft M, Rowa-Dewar N, Delles C, Gasevic D, Karaye KM. Rural–urban difference in the prevalence of hypertension in West Africa: a systematic review and meta-analysis. J Hum Hypertens. 2022.
Tateyama Y, Techasrivichien T, Musumari PM, Suguimoto SP, Ongosi AN, Zulu R, Dube C, Ono-Kihara M, Kihara M. Hypertension, its correlates and differences in access to healthcare services by gender among rural Zambian residents: a cross-sectional study. BMJ Open. 2022;12(4):e055668.
Reddy SP, Mbewu AD, Williams DR, Harriman NW, Sewpaul R, Morgan JW, Sifunda S, Manyaapelo T, Mabaso M. Race, geographical location and other risk factors for hypertension: South African National Health and Nutrition Examination Survey 2011/12. SSM Popul Health. 2021;16:100986.
Xing L, Jing L, Tian Y, Lin M, Du Z, Yan H, Ren G, Dong Y, Sun Q, Liu S. Urban–rural disparities in status of hypertension in northeast China: a population-based study, 2017–2019. Clin Epidemiol. 2019;11:801–20.
Li W, Gu H, Teo KK, Bo J, Wang Y, Yang J, Wang X, Zhang H, Sun Y, Jia X, et al. Hypertension prevalence, awareness, treatment, and control in 115 rural and urban communities involving 47 000 people from China. J Hypertens. 2016;34(1):39–46.
Zhang M, Wu J, Zhang X, Hu CH, Zhao ZP, Li C, Huang ZJ, Zhou MG, Wang LM. Prevalence and control of hypertension in adults in China, 2018. Zhonghua Liu Xing Bing Xue Za Zhi. 2021;42(10):1780–9.
Lei XY, Yin NN, Zhao YH. Socioeconomic status and chronic diseases: the case of hypertension in China. China Econ Rev. 2012;23(1):105–21.
Mohanty SK, Pedgaonkar SP, Upadhyay AK, Kämpfen F, Shekhar P, Mishra RS, Maurer J, O’Donnell O. Awareness, treatment, and control of hypertension in adults aged 45 years and over and their spouses in India: A nationally representative cross-sectional study. PLoS Med. 2021;18(8):e1003740.
Yusufali AM, Khatib R, Islam S, Alhabib KF, Bahonar A, Swidan HM, Khammash U, Alshamiri MQ, Rangarajan S, Yusuf S. Prevalence, awareness, treatment and control of hypertension in four Middle East countries. J Hypertens. 2017;35(7):1457–64.
Tang S, Meng Q, Chen L, Bekedam H, Evans T, Whitehead M. Tackling the challenges to health equity in China. Lancet. 2008;372(9648):1493–501.
Niu H, Tian M, Ma A, Wang C, Zhang L. Differences and determinants in access to essential public health services in China: a case study with hypertension people and under-sixes as target population. Chin Med J (Engl). 2014;127(9):1626–32.
Feng XL. Undiagnosed and uncontrolled chronic conditions in China: Could social health insurance consolidation make a change? Med Care Res Rev. 2018;75(4):479–515.
Qingyue M YH, Wen C, Qiang S, Xiaoyun L. People’s republic of China health system review. Manila: World Health Organization. Regional Office for the Western Pacific; 2015.
Qin J, Zhang Y, Fridman M, Sweeny K, Zhang L, Lin C, Mao L. The role of the Basic Public Health Service program in the control of hypertension in China: Results from a cross-sectional health service interview survey. PLoS ONE. 2021;16(6):e0217185.
Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet 2021; 398(10304):957–980.
Nwankwo T, Yoon SS, Burt V, Gu Q. Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011–2012. NCHS Data Brief. 2013;133:1–8.
Liu X, Gu W, Li Z, Lei H, Li G, Huang W. Hypertension prevalence, awareness, treatment, control, and associated factors in Southwest China: an update. J Hypertens. 2017;35(3):637–44.
Zhou J, Fang S. Association between Undiagnosed Hypertension and Health Factors among Middle-Aged and Elderly Chinese Population. Int J Environ Res Public Health. 2019;16(7):1214.
Rahman M. H SE, Islam MJ, Mostofa MG, Saadat KA: Association of socioeconomic status with diagnosis, treatment and control of hypertension in diabetic hypertensive individuals in Bangladesh: a population-based cross-sectional study. JRSM Open. 2015;6(10):2054270415608118.
Tang X, Xie X, Rao Z, Zheng Z, Hu C, Li S, Hu Z. Spatial analysis and comparison of the economic burden of common diseases: an investigation of 5.7 million rural elderly inpatients in Southeast China, 2010–2016. Front Public Health. 2021;9:774342.